Oncogene - Table of Contents alert Volume 30 Issue 32

Advertisement What will you think of the Frontiers publishing model?  "I have sincerely enjoyed the high quality articles published in your journal. I have also been extremely impressed and intrigued by your journal's innovative and unique approaches to review, evaluation, and distribution of research articles." Frontiers Author TABLE OF CONTENTS Volume 32, Issue 30 (July 2013) In this issue Review Original Articles Short Communication Oncogenomics Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Experimental & Molecular Medicine (EMM) TOP TEN As a new online-only open access journal, EMM seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. To view articles in the top ten full articles downloads, please visit: www.nature.com/emm/topten/index.html?WT.mc_id=TOC_EMM_1306_top Review Top The PGC-1/ERR signaling axis in cancer G Deblois, J St-Pierre and V Giguère Oncogene 2013 32: 3483-3490; advance online publication, December 3, 2012; 10.1038/onc.2012.529 Abstract | Full Text Original Articles Top Rac1 is required for Prkar1a-mediated Nf2 suppression in Schwann cell tumors P K Manchanda, G N Jones, A A Lee, D R Pringle, M Zhang, L Yu, K M D La Perle and L S Kirschner Oncogene 2013 32: 3491-3499; advance online publication, October 8, 2012; 10.1038/onc.2012.374 Abstract | Full Text Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers M K Y Siu, E S Y Wong, D S H Kong, H Y Chan, L Jiang, O G W Wong, E W-F Lam, K K L Chan, H Y S Ngan, X-F Le and A N Cheung Oncogene 2013 32: 3500-3509; advance online publication, September 3, 2012; 10.1038/onc.2012.363 Abstract | Full Text The E6AP E3 ubiquitin ligase regulates the cellular response to oxidative stress K Wolyniec, Y Levav-Cohen, Y-H Jiang, S Haupt and Y Haupt Oncogene 2013 32: 3510-3519; advance online publication, September 17, 2012; 10.1038/onc.2012.365 Abstract | Full Text CDK8 regulates E2F1 transcriptional activity through S375 phosphorylation J Zhao, R Ramos and M Demma Oncogene 2013 32: 3520-3530; advance online publication, September 3, 2012; 10.1038/onc.2012.364 Abstract | Full Text Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells D W Kang, W C Hwang, M H Park, G-H Ko, W-S Ha, K-S Kim, Y-C Lee, K-Y Choi and D S Min Oncogene 2013 32: 3531-3542; advance online publication, August 13, 2012; 10.1038/onc.2012.358 Abstract | Full Text PKA phosphorylation redirects ERα to promoters of a unique gene set to induce tamoxifen resistance R de Leeuw, K Flach, C Bentin Toaldo, X Alexi, S Canisius, J Neefjes, R Michalides and W Zwart Oncogene 2013 32: 3543-3551; advance online publication, August 20, 2012; 10.1038/onc.2012.361 Abstract | Full Text Short Communication Top RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination B H Lok, A C Carley, B Tchang and S N Powell Oncogene 2013 32: 3552-3558; advance online publication, September 10, 2012; 10.1038/onc.2012.391 Abstract | Full Text Oncogenomics Top The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells S Kalari, M Jung, K H Kernstine, T Takahashi and G P Pfeifer Oncogene 2013 32: 3559-3568; advance online publication, August 20, 2012; 10.1038/onc.2012.362 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.